Plus, a biotech with 'potentially game-changing' trial results, the 'too far, too fast' rally you might still be betting on, and more.
Oct 18, 2025
May 23, 2026
•
1 min read
Plus, a grid intelligence leader with a record $4.4B backlog.
May 16, 2026
Plus, a Top 1% analyst weighs in on Wall Street's biggest stock.
May 9, 2026
Plus, a Top 1% UBS stock picker sees almost 50% upside on this chipmaker, and more.